Volume 2, Issue 4, Pages e151-e158 (April 2015) Outcomes after viral load rebound on first-line antiretroviral treatment in children with HIV in the UK and Ireland: an observational cohort study Tristan Childs, MSc, Delane Shingadia, MD, Ruth Goodall, PhD, Katja Doerholt, MD, Hermione Lyall, MD, Trinh Duong, MSc, Ali Judd, PhD, Prof Di M Gibb, MD, Dr Intira Jeannie Collins, PhD The Lancet HIV Volume 2, Issue 4, Pages e151-e158 (April 2015) DOI: 10.1016/S2352-3018(15)00021-1 Copyright © 2015 Elsevier Ltd Terms and Conditions
Figure 1 Study profile ART=antiretroviral therapy. CHIPS=Collaborative HIV Paediatric Study. NRTI=nucleoside reverse transcriptase inhibitor. PI=protease inhibitor. The Lancet HIV 2015 2, e151-e158DOI: (10.1016/S2352-3018(15)00021-1) Copyright © 2015 Elsevier Ltd Terms and Conditions
Figure 2 Cumulative incidence of switch, resuppression without switch, and neither resuppression nor switch after viral load rebound Competing risk model. The Lancet HIV 2015 2, e151-e158DOI: (10.1016/S2352-3018(15)00021-1) Copyright © 2015 Elsevier Ltd Terms and Conditions